Long term safety of etanercept in elderly subjects with rheumatic diseases

R. Fleischmann; S. W. Baumgartner; M. H. Weisman; T. Liu; B. White; P. Peloso

doi:10.1136/ard.2005.035287

Long term safety of etanercept in elderly subjects with rheumatic diseases

R. Fleischmann, S. W. Baumgartner, M. H. Weisman, T. Liu, B. White, P. Peloso

Research output: Contribution to journal › Article › peer-review

101 Scopus citations

Abstract

Objectives: To determine the long term safety profile of the tumour necrosis factor (TNF) antagonist etanercept in subjects with rheumatoid arthritis (RA), psoriatic arthritis (PsA), or ankylosing spondylitis (AS) aged ≥65 years in comparison with subjects aged

Original language	English (US)
Pages (from-to)	379-384
Number of pages	6
Journal	Annals of the Rheumatic Diseases
Volume	65
Issue number	3
DOIs	https://doi.org/10.1136/ard.2005.035287
State	Published - Mar 2006
Externally published	Yes

ASJC Scopus subject areas

Rheumatology
Immunology

Access to Document

10.1136/ard.2005.035287

Cite this

@article{a7b5479ce6714887b7cb4134d0892ba2,

title = "Long term safety of etanercept in elderly subjects with rheumatic diseases",

abstract = "Objectives: To determine the long term safety profile of the tumour necrosis factor (TNF) antagonist etanercept in subjects with rheumatoid arthritis (RA), psoriatic arthritis (PsA), or ankylosing spondylitis (AS) aged ≥65 years in comparison with subjects aged ",

author = "R. Fleischmann and Baumgartner, {S. W.} and Weisman, {M. H.} and T. Liu and B. White and P. Peloso",

year = "2006",

month = mar,

doi = "10.1136/ard.2005.035287",

language = "English (US)",

volume = "65",

pages = "379--384",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "BMJ Publishing Group",

number = "3",

}

TY - JOUR

T1 - Long term safety of etanercept in elderly subjects with rheumatic diseases

AU - Fleischmann, R.

AU - Baumgartner, S. W.

AU - Weisman, M. H.

AU - Liu, T.

AU - White, B.

AU - Peloso, P.

PY - 2006/3

Y1 - 2006/3

N2 - Objectives: To determine the long term safety profile of the tumour necrosis factor (TNF) antagonist etanercept in subjects with rheumatoid arthritis (RA), psoriatic arthritis (PsA), or ankylosing spondylitis (AS) aged ≥65 years in comparison with subjects aged

AB - Objectives: To determine the long term safety profile of the tumour necrosis factor (TNF) antagonist etanercept in subjects with rheumatoid arthritis (RA), psoriatic arthritis (PsA), or ankylosing spondylitis (AS) aged ≥65 years in comparison with subjects aged

UR - http://www.scopus.com/inward/record.url?scp=33144490233&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33144490233&partnerID=8YFLogxK

U2 - 10.1136/ard.2005.035287

DO - 10.1136/ard.2005.035287

M3 - Article

C2 - 16150792

AN - SCOPUS:33144490233

SN - 0003-4967

VL - 65

SP - 379

EP - 384

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - 3

ER -

Long term safety of etanercept in elderly subjects with rheumatic diseases

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this